[Guiding principles for industrial policy in the pharmaceutical sector of the European Community. European Economic Community].
The aim of this work is to present the guidelines suggested by the E. Community for an industrial policy concerning the Pharmaceutical sector, within the framework of a common plan encompassing health, industrial growth and employment. In addition, as there are signs of structural difficulties in the pharmaceutical industries of the Community which are yielding ground in comparison with their main worldwide competitors, suggestions are made for a reversal of this trend. Larger financial support is needed for research and development (RD) of new therapeutically innovative medicines, which is a condition for its long term competitiveness, and a stricter prices control by the Community over national regulations is also strongly advised.